Healthcare Global Enterprises Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) & 31(5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. B.S. Ajaikumar, the Promoter of Healthcare Global Enterprises, has filed a declaration under SEBI Takeover Regulations disclosing share encumbrances for FY 2024-25. During the year, he encumbered 18,92,539 equity shares on March 12, 2025, which was already disclosed to stock exchanges on March 17, 2025. Including prior encumbrances from FY 2020-21 (29,77,000 shares) and FY 2022-23 (90,000 shares), total encumbered shares stand at 49,59,539, representing 3.56% of the company's paid-up capital as of March 31, 2025. No other encumbrances were made by the promoter or persons acting in concert during the year.
The promoter has pledged 3.56% of paid-up capital, which is a moderate level and not a major concern. Investors should monitor for any further encumbrances or invocation, as increased pledging can signal financial stress. The fact that this is a routine annual declaration with no new large-scale pledging is mildly reassuring.